[1
]
Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer
Center, Tampa, Florida. Electronic address: nelli.bejanyan@moffitt.org.
[2
]
Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin.
[3
]
Adult Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota.
[4
]
Memorial Sloan Kettering Cancer Center, New York, New York.
[5
]
Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer
Center, Tampa, Florida.
[6
]
Division of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona,
Spain.
[7
]
Division of Hematology, Department of Internal Medicine, University Hospital Basel,
Basel, Switzerland.
[8
]
Beth Israel Deaconess Medical Center, Boston, Massachusetts.
[9
]
Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium
Health, Charlotte, North Carolina.
[10
]
Department of Hematology/Oncology, Johns Hopkins All Children's Hospital, St Petersburg,
Florida.
[11
]
Haematology Research Centre, Department of Immunology and Inflammation, Imperial College
London, London, UK.
[12
]
Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, Georgia.
[13
]
Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic,
Jacksonville, Florida.
[14
]
Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid,
Spain.
[15
]
Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas
Health System, Kansas City, Kansas.
[16
]
Section of Medical Oncology, Department of Internal Medicine, Yale New Haven Hospital,
New Haven, Connecticut.
[17
]
Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherland.
[18
]
Stem Cell Transplant Program, Division of Hematology/Oncology, Department of Medicine,
Loyola University Chicago Stritch School of Medicine, Maywood, Illinois.
[19
]
Blood & Marrow Transplant Program, Department of Medicine, Ottawa Hospital Ottawa,
Ontario, Canada.
[20
]
Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical
Center, Nashville, Tennessee.
[21
]
Experimental Transplantation and Immunology Branch, Center for Cancer Research, National
Cancer Institute, National Institutes of Health, Bethesda, Maryland.
[22
]
Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department
of Pediatrics, New York Medical College, Valhalla, New York.
[23
]
Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson
Cancer Center, Houston, Texas.
[24
]
Department of Hematology, Academische Ziekenhuis, Maastricht, The Netherlands.
[25
]
Division of Medical Oncology, Markey Cancer Center, University of Kentucky School
of Medicine, Lexington, Kentucky.
[26
]
Department of Medicine, University Hospitals Cleveland Medical Center, Case Western
Reserve University, Cleveland, Ohio.
[27
]
Department of Hematology, CHU Grenoble Alpes, Grenoble, France.
[28
]
Department of Internal Medicine, Maastricht University Medical Centre, Maastricht,
The Netherlands.
[29
]
Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham,
North Carolina.
[30
]
Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department
of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore,
Maryland.
[31
]
Hematopoietic Stem Cell Transplant Program, Texas Transplant Institute, San Antonio,
Texas.
[32
]
Division of Hematology/Oncology, Department of Medicine, University of Massachusetts
Medical Center, Worcester, Massachusetts.
[33
]
Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh,
Saudi Arabia.
[34
]
Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
[35
]
Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department
of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
[36
]
Department of Hematology, Inselspital, Bern University Hospital, University of Bern,
Switzerland.
[37
]
Section of Bone Marrow Transplantation and Cellular Therapy, Division of Hematology,
Oncology and Cell Therapy, Department of Internal Medicine, Rush Medical College,
Chicago, Illinois.
[38
]
Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, Pennsylvania.
[39
]
Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
[40
]
Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre
for Clinical Research Sormland, Uppsala University, Sweden.
[41
]
Department of Haematology, Christian Medical College, Vellore, India.
[42
]
Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center,
Cleveland, Ohio.
[43
]
Laboratory of Myeloid Malignancies, National Heart Lung and Blood Institute, National
Institutes of Health, Bethesda, Maryland.
[44
]
Division of Medical Oncology, University of Washington and Clinical Research Division,
Fred Hutchinson Cancer Research Center, Seattle, Washington.
[45
]
Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, Minnesota.
[46
]
Division of Hematology, Oncology and Transplantation, Department of Medicine, University
of Minnesota, Minneapolis, Minnesota, 96.
